Which factors influence the resort to surrogate consent in stroke trials, and what are the patient outcomes in this context?

BMC Medical Ethics

Volumn 16, Issue 1, 2015, Pages

  Mendyk, Anne Marie ^a   Labreuche, Julien ^a   Henon, Hilde ^a   Girot, Marie ^b   Cordonnier, Charlotte ^a   Duhamel, Alain ^a   Leys, Didier ^a   Bordet, Régis ^a  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; APHASIA; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITIVE DEFECT; DECISION MAKING; ETHICS; FEMALE; HUMAN; INFORMED CONSENT; MALE; MEDICAL RESEARCH; METHODOLOGY; MIDDLE AGED; PATIENT SELECTION; PROXY; RESEARCH SUBJECT; SEVERITY OF ILLNESS INDEX; UNITED STATES; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; APHASIA; BIOMEDICAL RESEARCH; COGNITION; COGNITION DISORDERS; DECISION MAKING; FEMALE; HUMANS; INFORMED CONSENT; MALE; MIDDLE AGED; PATIENT SELECTION; PROXY; RESEARCH DESIGN; RESEARCH SUBJECTS; SEVERITY OF ILLNESS INDEX; STROKE; UNITED STATES;

EID: 84928526094     PISSN: None     EISSN: 14726939     Source Type: Journal    
DOI: 10.1186/s12910-015-0018-8     Document Type: Article

References (21)

1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371:1612-23.
2. Libersa C, Berger F, Courcier-Duplantier S, Marey C. The challenges of the implementation of the European Directive 2001/20/THIS in the hand Member States. Therapie. 2003;58:549-51.
3. Govindarajan P, Dickert NW, Meeker M, Of Souza N, Harney D, Hemphill CJ, et al. Emergency research: using exception from informed consent, evaluation of community consultations. Acad Emerg Med. 2013;20:98-103.
4. Rose DZ, Kasner SE. Informed consent: the rate-limiting step in acute stroke. Front Neurol. 2011;2:65.
5. Iwanowski P, Budaj A, Czlonkowska A, Wasek W, Kozlowska-Boszko B, Oledzka U, et al. Informed consent for clinical trials in acute coronary syndromes and stroke following the European Clinical Trials Directive: investigators' esperiences and attitudes. Trials. 2008;9:45.
6. Brady MC, Frederick A, Williams B. People with aphasia: capacity to consent, research anticipation and intervention inequalities. Int J Stroke. 2013;8:193-6.
7. Ali M, Bath PM, Lyden PD, Bernhardt J, Brady M. Representation of people with aphasia in randomized controlled trials of acute interventions. Int J Stroke. 2014;9:174-82.
8. Henon H, Durieu I, Guerouaou D, Lebert F, Pasquier F, Leys D. Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology. 2001;57:1216-22.
9. Flaherty ML, Karlawish J, Khoury JC, Kleindorfer D, Woo D, Broderick JP. How significant is surrogate consent for stroke research? Neurology. 2008;71:1566-71.
10. Kasner SE, DelGiudice A, Rosenberg S, Sheen M, Luciano JM, Cucchiara BL, et al. Who will participate in acute stroke trials? Neurology. 2009;72:1682-8.
11. Demarquay G, Derex L, Nighoghossian N, Adeleine P, Philippeau F, Honnorat J, et al. Ethical issues of informed consent in acute stroke. Analysis of the modalities of consent in 56 patients enrolled in urgent therapeutic trials. Cerebrovasc Dis. 2005;19:65-8.
12. Dani KA, McCornick MT, Muir KW. Brain lesion volume and capacity for consent in stroke trials: Potential regulatory barriers to the use of surrogate markers. Stroke. 2008;39:2336-40.
13. Kane I, Lindley R, Lewis S, Sandercock P. Impact of stroke syndrome and stroke severity on the process of the consent in the Third International Stroke Trial. Cerebrovasc Dis. 2006;21:348-52.
14. Adams Jr HP, Bendixen BH, Kappelle LJ, the TOAST investigators. Classification of subtypes of acute ischemic stroke. Definitions for use in multicenter clinical trial. Stroke. 1993;24:35-41.
15. Deplanque D, Masse I, Lefebvre C, Libersa C, Leys D, Bordet R. Prior TIA, lipid-lowering drug use and physical activity decrease ischemic stroke severity. Neurology. 2006;67:1403-10.
16. Stein J, Brady Wagner LC. Is informed consent a "Yes or No" response? Enhancing the shared decision-making process for persons with aphasia. Top Stroke Rehabil. 2006;13:42-6.
17. Ducrocq X, Taillandier L, Anxionnat R, Lacour JC, Debouverie M, Lanotte L, et al. Ethical approach to informed consent for participation in clinical studies in acute cerebral infarct. Presse Med. 2000;29:1335-40.
18. Kleindorf D, Linsell CJ, Alwell K, Woo D, Flaherty ML, Eilerman J, et al. Ischemic stroke survivor's opinion regarding research utilizing exception from informed consent. Cerebrovasc Dis. 2011;32:321-6.
19. Goldstein JN, Espinola JA, Fisher J, Pallin DJ, Camargo Jr CA. Public opinion of stroke clinical trial using exception from informed consent. Int J Emerg Med. 2010;3:385-9.
20. Chen DT, Case DL, Brott TG, Brown RD, Silliman SL, Meschia JF, et al. Impact of restrincting enrollment in stroke genetics research to adults able to provide informed consent. Stro ke. 2008;39:831-7.
21. Rosenbaum JR, Bravata DM, Concato J, Brass LM, Kim N, Fried TR. Informed consent for thrombolytic therapy for patients with acute ischemic stroke treated in routine clinical practice. Stroke. 2005;36:528-9.